US-Iran Ceasefire Hopes Fade: ETF Strategies to Play

U.S.-Iran tensions rise as Hormuz risks grow. Markets turn volatile -- dividend, low-beta, and defensive ETFs may help cushion portfolios.

Zacks Investment Research • May 6, 2026

Medical Technology Stocks: Innovation Endures As Valuations Reset

Investors are questioning the staying power of medical technology (medtech) stocks, which have fallen from grace since the COVID-19 pandemic. The starting point is to distinguish between medtech and other healthcare industries.

Seeking Alpha • May 2, 2026

Goldman Sachs Lifts UnitedHealth Target Price: Healthcare ETFs to Watch

Goldman lifts UnitedHealth's target price, spotlighting ETFs like IHF as diversified ways to tap its growth while cushioning Medicaid-driven risks.

Zacks Investment Research • Apr 27, 2026

Trump's Psychedelics Stance Reignites Sector - How Investors Can Benefit

Recent White House and FDA actions fast-track psychedelic depression drug approvals, granting priority review vouchers and accelerating rescheduling for eligible therapies. Compass Pathways leads with a CNPV for COMP360 in treatment-resistant depression, positive Phase 3 data, and a sub-$1bn market cap suggesting potential upside.

Seeking Alpha • Apr 27, 2026

Should You Invest in the Vanguard Health Care Index Fund ETF Shares (VHT)?

If you're interested in broad exposure to the Healthcare - Broad segment of the equity market, look no further than the Vanguard Health Care Index Fund ETF Shares (VHT), a passively managed exchange traded fund launched on January 26, 2004.

Zacks Investment Research • Apr 16, 2026

1 No-Brainer Healthcare Vanguard ETF to Buy Right Now for Less Than $1,000

Expected increased capital spending and the implementation of artificial intelligence (AI) are structural tailwinds for healthcare stocks today. Spending is expected to be 20% of GDP by 2032.

The Motley Fool • Apr 13, 2026

Global PMI: Tracking The Sectors Hit Hardest By The Middle East War

Survey data underscored how the war in the Middle East has already had a material impact on economic growth around the world. Drilling down deeper, the data showed weaker growth trends were recorded across all major industries globally.

Seeking Alpha • Apr 12, 2026

Can Forgotten Biotech Break Out?

After a 50%+ run from lows last April through highs in mid-January, the Biotech group has been trending sideways over the last few months. Biotech hasn't garnered much attention lately, with all the coverage of the Iran War and the AI Doom trade that's been taking down software stocks even as AI infrastructure stocks continue to surge.

Seeking Alpha • Apr 11, 2026

3 ETFs to Own if the U.S. Economy Slows in 2026

Many portfolios are still very heavy in tech and growth stocks. It's time to revisit asset allocations.

The Motley Fool • Mar 30, 2026

VHT Lagged the Market by 57 Points Over 5 Years. Here Is Why Long-Term Investors Still Hold It

Healthcare spending doesn't stop during recessions. That structural reality is the core argument for owning Vanguard Health Care ETF (NYSEARCA:VHT), a pure-play sector fund that has quietly compounded wealth for long-term investors while offering insulation from economic cycles that most equity sectors can't match.

24/7 Wall Street • Mar 26, 2026